Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Sales | 125,864 | 62,622 | 68,642 | 68,817 | 106,532 |
| Gross Profit | 125,864 | 62,622 | 68,642 | 68,817 | 106,532 |
| Operating Expenses | 5,590 | 4,693 | 15,911 | 11,999 | 10,925 |
| Operating Income | 120,274 | 57,929 | 52,731 | 56,818 | 95,607 |
| Interest Expense | 3,357 | 3,574 | 3,554 | 3,555 | 3,555 |
| Other Income | 1,505 | 336 | 2,361 | 3,209 | 4,467 |
| Pre-tax Income | 118,422 | 54,691 | 51,538 | 56,472 | 96,519 |
| Income Tax | 41,185 | 17,234 | -3,854 | 6,161 | 1,673 |
| Net Income Continuous | 77,237 | 37,457 | 55,392 | 50,311 | 94,846 |
| Net Income Discontinuous | N/A | N/A | -14,753 | 5,380 | -60,914 |
| Net Income | $77,237 | $37,457 | $40,639 | $55,691 | $33,932 |
| EPS Basic Total Ops | 0.65 | 0.31 | 0.35 | 0.47 | 0.29 |
| EPS Basic Continuous Ops | 0.65 | 0.31 | 0.47 | 0.42 | 0.80 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.12 | 0.05 | -0.51 |
| EPS Diluted Total Ops | 0.47 | 0.23 | 0.38 | 0.38 | 0.24 |
| EPS Diluted Continuous Ops | 0.46 | 0.22 | 0.19 | 0.34 | 0.63 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.19 | 0.04 | -0.39 |
| EBITDA(a) | $120,866 | $59,401 | $57,807 | $61,822 | $101,367 |